Deep Anterior Lamellar Keratoplasty Versus Penetrating Keratoplasty for Macular Corneal Dystrophy

ISRCTN ISRCTN41152132
DOI https://doi.org/10.1186/ISRCTN41152132
Secondary identifying numbers Kartal Training and Research Hospital 102
Submission date
03/02/2013
Registration date
12/02/2013
Last edited
03/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Macular corneal dystrophy (MCD) is characterized by multiple, grayish-white stromal opacities with indistinct and hazy borders that extend from limbus to limbus (limbus is the part between the cornea and the white of the eye). As corneal opacity slowly increases and involves the visual axis, loss of functional visual acuity occurs. A transplantation of corneal material called keratoplasty eventually becomes necessary for the restoration of vision and the recovery of corneal transparency. Penetrating keratoplasty (PK) is the traditional treatment for a variety of corneal pathologies including corneal stromal dystrophies. However, deep anterior lamellar keratoplasty (DALK) is currently considered to be the first-choice surgical procedure in patients with corneal disease not involving the endothelium, such as keratoconus, stromal scars and stromal dystrophies. The main advantage of DALK is that the patient’s own endothelium is retained, which eliminates the risk of endothelial graft rejection and preserves endothelial cell density. The aim of the study was to compare which of deep anterior lamellar keratoplasty (DALK) or penetrating keratoplasty (PK) worked better for macular corneal dystrophy (MCD).

Who can participate?
Patients (Turkish and aged between 16 to 67 years) requiring keratoplasty for the treatment of macular corneal dystrophy without endothelial involvement were enrolled.

What does the study involve?
Patients underwent two different keratoplasty techniques. All eyes were randomly allocated to a number on a surgical chart (even numbers received DALK, odd numbers received PK).

What are the possible benefits and risks of participating.
Benefits: patients treated with keratoplasty for the restoration of vision and the recovery of corneal transparency.
Risks: possibility of complications such as loss of endothelial cell density, graft rejection, recurrence of the disease.

Where is the study run from?
The study ran from one single centre at the Kartal Training and Research Hospital (Turkey).

When is study starting and how long is it expected to run for?
The study ran between January 2006 and June 2010.

Who is funding the study?
No government or non-governmental financial support.
Dr Esin Sogutlu Sarý based at Kartal Training and Research Hospital, Akdeniz University Scientific Research Projects Unit (Turkey)

Who is the main contact
Dr Esin Sogutlu Sarý
dresinsogutlu@gmail.com

Contact information

Dr Esin Sogutlu Sarı
Scientific

Paşaalanı mah. 253. sok Deniz 2 apt no:18/4
Balıkesir
10234
Türkiye

Email dresinsogutlu@gmail.com

Study information

Study designRandomised interventional case series
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleDeep Anterior Lamellar Keratoplasty Versus Penetrating Keratoplasty for Macular Corneal Dystrophy: a randomised controlled trial
Study objectivesDeep anterior lamellar keratoplasty eliminates the risk of endothelial graft rejection and preserves endothelial cell density compared to penetrating keratoplasty in macular corneal dystrophy.
Ethics approval(s)Received from the local medical ethics committee (ref:102)
Health condition(s) or problem(s) studiedMacular corneal dystrophy
InterventionTwo different keratoplasty technique: Deep anterior lamellar keratopalsty vs Penetrating keratoplasty.
Intervention typeOther
Primary outcome measureA complete ophthalmologic examination was performed before the operation and postoperative visit in both groups. The examination included logMAR uncorrected visual acuity (UCVA), logMAR best-corrected visual acuity (BCVA), manifest refraction, slit lamp biomicroscopy, and corneal topographic analysis with the CSO topography system (Costruzione Strumenti Oftalmici, Firenze, Italy). Contrast sensitivity measurements and corneal aberrometric analysis were also performed postoperatively after all sutures were finally removed. The CSV-1OOOE chart (VectorVision, Greenville, Ohio, USA) was used for the assessment of contrast sensitivity. This test consists of four rows of sinewave gratings (3, 6, 12, 18 cycles/degree) that had to be observed by the patient with full correction in place at a distance of 2.5 m. After an initial demonstration, the contrast threshold was measured for each spatial frequency. All patients were tested under both mesopic and photopic conditions and the results were expressed in log units of contrast sensitivity. Corneal aberrometry was recorded and analyzed with the CSO topography system whose software automatically converts the corneal elevation profile into corneal wavefront data using Zernike polynomials with an expansion up to the 7th order. The corneal aberration coefficients and root mean square (RMS) values were calculated for a 6.0 mm pupil.
ECD of donor corneas were assessed by a specular microscope before storage in Optisol medium. The endothelium was photographed and evaluated using a Topcon SP 2000p noncontact specular microscope (Topcon Corp., Tokyo, Japan). Images of the central corneal window were reviewed by the same observer (E. S.) and manual correction of the cell borders was performed before final analysis of the endothelium. Twenty endothelial cells were marked for each analysis. For each examination, three measurements of ECD were averaged.
Secondary outcome measuresSurgical complications
Overall study start date01/01/2006
Completion date01/06/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants82 eyes of 29 male and and 24 female patients included.
Key inclusion criteriaMale and female patients aged between 16 and 67 requiring keratoplasty for the treatment of macular corneal dystrophy without endothelial involvement were included.
Key exclusion criteriaPatients who were lost to follow-up, had previous eye surgery or who underwent additional surgery combined with keratoplasty were excluded from the data analysis.
Date of first enrolment01/01/2006
Date of final enrolment01/06/2010

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Paşaalanı mah. 253. sok Deniz 2 apt no:18/4
Balıkesir
10234
Türkiye

Sponsor information

Kartal Training and Research Hospital (Turkey)
Hospital/treatment centre

Cevizli
Istanbul
34404
Türkiye

Email dresinsogutlu@gmail.com
ROR logo "ROR" https://ror.org/01c2wzp81

Funders

Funder type

Hospital/treatment centre

Kartal Training and Research Hospital, Akdeniz University Scientific Research Projects Unit (Turkey)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan